Business Wire

The IKEA Foundation Pledges More Than €11 Million in Emergency Humanitarian Aid for Sudan

8.6.2023 13:23:00 EEST | Business Wire | Press release

Share

The IKEA Foundation has donated €5 million to Médecins Sans Frontières - Doctors Without Borders (MSF) to provide urgent medical care and supplies to people affected by the recent fighting in Sudan. It has also donated €6.7 million to Better Shelter to deploy 3,000 units to meet the immediate shelter needs of people displaced by the deadly conflict.

This press release features multimedia. View the full release here: https://www.businesswire.com/news/home/20230608005375/en/

To view this piece of content from mms.businesswire.com, please give your consent at the top of this page.

Illustration of fighting in Khartoum, Sudan Copyright: MSF/Atsuhiko Ochiai Countries: Sudan Date taken / Date Recorded: 04 May, 2023 Caption / Description: Aerial view captures the fighting and violence that erupted in Khartoum, Sudan. (Photo: Business Wire)

Intense fighting broke out in Khartoum, Sudan on 15 April and has since spread to other parts of the country. Local hospitals have been overwhelmed as people arrive with serious injuries caused by gunshots, explosions and airstrikes. The country’s health system, which has been struggling for decades, is facing a huge increase in needs and a shortage of supplies.

Within Sudan, many of those forced to flee are arriving in overcrowded urban areas already hosting internally displaced people. Sudan is also hosting more than one million refugees who have fled violence in neighbouring countries. This is placing immense strain on overstretched resources and exposing vulnerable people to risks such as evictions, family separation and gender-based violence.

Per Heggenes, CEO of the IKEA Foundation, said: “The violence in Sudan is a devastating human tragedy. It is our responsibility to alleviate the suffering of those caught in the crossfire. We strongly urge other funders to join us in delivering life-saving humanitarian assistance to Sudan. Let’s come together and make a tangible difference in the lives of those devastated by the conflict”

Urgent life-saving care by MSF

The IKEA Foundation’s donation will help MSF provide life-saving care both through medical interventions and by distributing supplies. It will also contribute to supporting MSF's activities across 10 states in Sudan. MSF teams have been treating war wounded, providing healthcare services and supplies, and water and sanitation.

Stephen Cornish – Director General – Médecins Sans Frontières (MSF) – Geneva Operational Centre said: “As the conflict in Sudan spirals into its second month and humanitarian needs outstrip response capacity, IKEA Foundation’s backing of our medical work across the country marks a collective resolution to take all possible measures to support those caught in the violence.

“The contribution is a testament to the determination and professionalism of our teams on the ground, who despite the many challenges and obstacles remain committed to extending life-saving healthcare. We are deeply thankful for the steadfast support of the IKEA Foundation. Today’s donation of €5 million will go a long way in helping us to provide humanitarian and medical aid to those most affected by the ongoing crisis.”

Immediate shelter needs by Better Shelter

An estimated 1.4 million Sudanese people have been displaced by this conflict already. This includes people fleeing internally and those crossing borders into neighbouring countries, including Chad and Ethiopia. Food, shelter, and protection services are among people’s urgent needs. To meet the immediate need for shelter as expressed by UNHCR, the UN Refugee Agency, Better Shelter will deploy 3,000 units immediately to neighbouring countries.

Johan Mast, Acting Manager Director, Better Shelter, said: “The current situation in Sudan is alarming. Millions of people are experiencing insecurity, food and water scarcity, and various challenges that require urgent attention. We are very grateful for the IKEA Foundation stepping in to assist and pleased to offer shelter to 15,000 individuals affected by the crisis. Shelter is a fundamental human need that provides physical protection and helps with emotional healing and recovery from the traumatic experiences they have endured.”

About the IKEA Foundation

The IKEA Foundation is a strategic philanthropy that focuses its grant making efforts on tackling the two biggest threats to children’s futures: poverty and climate change. It currently grants more than €200 million per year to help improve family incomes and quality of life while protecting the planet from climate change. Since 2009, the IKEA Foundation has granted more than €1.8 billion to create a better future for children and their families.

In 2021 the Board of the IKEA Foundation decided to make an additional €1 billion available over the next five years to accelerate the reduction of Greenhouse Gas emissions.

When an emergency strikes, time is of the essence. To provide the most efficient response, the IKEA Foundation provides extraordinary emergency funding to a select few partner organisations, who work mainly in Africa, Asia and the Middle East. In 2023 we have provided more than €31 Million in emergency funding.

About Médecins Sans Frontières

Médecins Sans Frontières (MSF) translates to Doctors without Borders, is a non-profit, self-governed, member-based organisation. MSF provides medical assistance to people affected by conflict, epidemics, disasters, or exclusion from healthcare. MSF teams are made up of tens of thousands of health professionals, logistic and administrative staff. Their actions are guided by medical ethics and the principles of impartiality, independence and neutrality.

Since 1978, as a first-hand witness and responder to the dire needs of the Sudanese people, MSF has mobilised teams across 12 states, implemented around 20 projects from primary and secondary healthcare, mobile clinics, nutrition, reproductive and mental healthcare to vaccination, health promotion, and water and sanitation.

About Better Shelter

Better Shelter is a humanitarian non-profit organisation based in Sweden. It started developing temporary shelters more than ten years ago, with a big mission dedicated to sheltering displaced persons with safety, dignity and hope on their path towards a more stable life in a permanent home of their own. While its work has grown in scale, the small team continues to support partners and deliver shelters internationally from warehouses in Poland, Türkiye, and Panama.

Since 2015, Better Shelter has delivered more than 85,000 shelters to emergency, crisis, and development programs in over 80 countries. Better Shelter has impacted the lives of hundreds of thousands of displaced persons through collaborations with humanitarian NGOs and INGOs, UN bodies, philanthropic foundations, and academic institutions, including the UN Refugee Agency, UNHCR, the IKEA Foundation and the Aga Khan Agency for Habitat. www.bettershelter.org

To view this piece of content from cts.businesswire.com, please give your consent at the top of this page.

Contact information

Lotika Mehta, lotika.mehta@ikeafoundation.org

About Business Wire

For more than 50 years, Business Wire has been the global leader in press release distribution and regulatory disclosure.

Subscribe to releases from Business Wire

Subscribe to all the latest releases from Business Wire by registering your e-mail address below. You can unsubscribe at any time.

Latest releases from Business Wire

Incyte Announces Positive CHMP Opinion for Zynyz ® (retifanlimab) for First-Line Treatment of Advanced Squamous Cell Carcinoma of the Anal Canal (SCAC)30.1.2026 16:29:00 EET | Press release

Incyte (Nasdaq:INCY) today announced that the Committee for Medicinal Products for Human Use (CHMP) of the European Medicines Agency (EMA) has issued a positive opinion recommending the approval of Zynyz® (retifanlimab) in combination with carboplatin and paclitaxel (platinum-based chemotherapy) for the first-line treatment of adult patients with metastatic or with inoperable locally recurrent squamous cell carcinoma of the anal canal (SCAC). “Today’s positive CHMP opinion is an important step towards addressing the urgent need for new treatment options for patients in Europe with advanced SCAC, a disease which has seen limited innovation for decades,” said Lee Heeson, Executive Vice President and Head of Incyte International. “If approved, Zynyz in combination with platinum-based chemotherapy has the potential to become a new standard-of-care for patients living with this rare and difficult-to-treat cancer.” The positive CHMP opinion was based on data from the Phase 3 POD1UM-303/Inter

Mediawan to Acquire The North Road Company, Creating a New Global Independent Content Platform30.1.2026 14:32:00 EET | Press release

Mediawan, the leading independent European studio led by Pierre-Antoine Capton, co-founded by Capton, Xavier Niel and Matthieu Pigasse, today announced the signing of an agreement to acquire The North Road Company (“North Road”), the preeminent independent U.S.-based studio founded by Peter Chernin. The combination creates one of the world’s largest independent studios with major creative hubs in the five continents and capabilities spanning all genres, formats and audiences. Together, Mediawan and North Road will have a stronger ability to accelerate the development of powerful IP, foster fresh creative synergies through format adaptations and co-production opportunities, and deliver ever greater value to viewers, talent and partners worldwide. The acquisition brings together two of the most dynamic independent studios in the sector with world-class creative talent, premium IP, and the scale to deliver content at the highest level. In an industry undergoing significant consolidation,

BrightSign Powers Intelligent Signage Experiences at ISE 202630.1.2026 10:00:00 EET | Press release

With more industries embracing the power of visual storytelling, BrightSign, the provider of the most advanced, capable, and trusted digital media players and operating system, will showcase the latest developments in digital signage technology at ISE 2026 in Barcelona, Spain from February 3-6, 2026. BrightSign’s latest innovations come to life at booth #4S-150 through interactive real-world demos featuring retail, QSR, transportation, and corporate use cases. Visitors can test new AI-powered object detection capabilities of BrightSign players, allowing them to pick up an object and see the content on the screen respond immediately. Booth activations will be powered by BrightSign’s reliable platform including bsn.Control, BrightSignOS™, brightAuthor connected, and its global partner ecosystem. “In today’s immersive, personalized and visual world, the stakes have never been higher for powerful, secure, reliable, and intelligent digital signage,” said Steve Durkee, chief executive office

Candela Ushers in a New Era of Aesthetic Innovation at IMCAS Paris With the Launch of the Glacē™ System30.1.2026 09:30:00 EET | Press release

Candela, a global leader in energy-based aesthetic technologies, today announced the European launch of the Glacē™ System, a facial treatment platform that signals a bold new chapter for the company and the future of aesthetic medicine. In addition to the launch of the Glacē System, Candela will also showcase its Matrix system for radiofrequency-based skin renewal and its iconic Vbeam® Pro vascular treatment platform at IMCAS 2026. Both Matrix and VBeam Pro platforms are currently available in select EMEA markets and are expected to be comprehensively launched shortly, further strengthening Candela’s leadership in the energy-based device market. Unveiled at the IMCAS World Congress 2026, these launches underscore Candela’s continued commitment to delivering innovative, science-backed treatment solutions for high-demand patient needs. Candela leads the industry in clinical efficacy and safety, supported by one of the largest bodies of published clinical data backed by decades of clinica

Merz Therapeutics Appoints Dan Staner as President, Region Europe30.1.2026 09:00:00 EET | Press release

Merz Therapeutics today announced the appointment of Dan Staner as President, Region Europe, effective February 1, 2026. In this role, Dan will oversee the company’s European business and drive regional growth. Dan will report directly to Merz Therapeutics Chief Executive Officer, Stefan König, and will join the Therapeutics Executive Team. His appointment reflects the company’s continued commitment to strengthening its leadership capabilities and accelerating its growth strategy across key European markets.​ “Dan brings a strong track record of building and scaling biopharmaceutical businesses across Europe,” said Stefan König, CEO of Merz Therapeutics. “His deep commercial, strategic, and regional leadership experience will be instrumental in advancing our growth ambitions, expanding patient access to our therapies, and further strengthening our presence in Europe. We are very pleased to welcome Dan to Merz Therapeutics.”​ Throughout his career, Dan has held senior leadership roles i

In our pressroom you can read all our latest releases, find our press contacts, images, documents and other relevant information about us.

Visit our pressroom
World GlobeA line styled icon from Orion Icon Library.HiddenA line styled icon from Orion Icon Library.Eye